Document is current

Any future updates will be listed below

Effektive Lipidkontrolle mit Alirocumab schon in der Primärprävention

Crossref DOI link: https://doi.org/10.1007/s15027-025-3746-9

Published Online: 2025-02-22

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark